Bioanalysis and Biomarker Services
Product Description
Crystal Pharmatech
-
Country/Region:China
-
On CPHI since:2024
-
Certificates:2
Crystal Pharmatech
-
Country/Region:China
-
On CPHI since:2024
-
Certificates:2
More Products from Crystal Pharmatech (4)
-
Product CMC Analytical Services for Biologics, ADCs, and CGT
Crystal Bio Solutions operates a 5,300 sq ft CMC analytical lab in New Jersey that supports programs from discovery through IND and BLA. We develop, qualify, and validate phase-appropriate methods and deliver inspection-ready data packages. Modalities include monoclonal and bispecific antibodies, proteins,... -
Product Integrated Formulation Development, GMP Manufacturing & Global Delivery
Crystal Pharmatech provides end-to-end oral solid dose development, injectable, lipid-based formulation development, and clinical manufacturing under one roof—seamlessly uniting enabling technologies for insoluble drugs (spray-dried ASDs, hot-melt extrusion, lipid and nano platforms) with conventional and ... -
Product Integrated Small Molecule CRO Platforms
This service unifies material-sparing FAST analytics, solid-state research, lab-scale crystallization development, and pre-formulation into a single early-development track that turns scarce API into decision-ready insight and scale-transferable processes. We start with focused solid-state testing to revea... -
Product Mol2Med™ Developability Assessment
Mol2Med is a modular, material-sparing path that integrates experimental testing, PBPK modeling, and form selection from API profiling through preclinical formulation design. Selected for first-time-right decisions on aggressive timelines, it can deliver go/no-go answers in ≤4 weeks with ≥500 mg API while ...
Crystal Pharmatech resources (2)
-
Brochure Crystal Pharmatech Company Overview
Small Molecule CRO/CDMO Business Unit Overview of Crystal Pharmatech -
Brochure Crystal Bio Solutions Company Overview
Crystal Bio Solutions, a Crystal Pharmatech subsidiary: US CRO for GLP/GCLP bioanalysis, biomarkers, clinical research, regulatory support, and CMC analytics。



